Brogan & Partners - Sites@Duke | sites.duke.edusites.duke.edu/malaria/files/2012/07/Turusov-et-al_2002.pdf · 2012. 9. 24. · Moscow, Russia. Telephone: 7 095 323-5500. Fax: 7 095

Brogan & Partners

Dichlorodiphenyltrichloroethane (DDT): Ubiquity, Persistence, and RisksAuthor(s): Vladimir Turusov, Valery Rakitsky and Lorenzo TomatisReviewed work(s):Source: Environmental Health Perspectives, Vol. 110, No. 2 (Feb., 2002), pp. 125-128Published by: Brogan & PartnersStable URL: http://www.jstor.org/stable/3455368 .Accessed: 23/09/2012 20:42

Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at .http://www.jstor.org/page/info/about/policies/terms.jsp

.JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range ofcontent in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new formsof scholarship. For more information about JSTOR, please contact [email protected].

.

The National Institute of Environmental Health Sciences (NIEHS) and Brogan & Partners are collaboratingwith JSTOR to digitize, preserve and extend access to Environmental Health Perspectives.

http://www.jstor.org

http://www.jstor.org/action/showPublisher?publisherCode=brogpart

http://www.jstor.org/stable/3455368?origin=JSTOR-pdf

http://www.jstor.org/page/info/about/policies/terms.jsp

Review

Dichlorodiphenyltrichloroethane (DDT): Ubiquity, Persistence, and Risks Vladimir Turusov, Valery Rakitsky,2 and Lorenzo Tomatis3

1N.N. Blokhin Russian Cancer Research Centre, Moscow, Russian Federation; 2F.F. Erisman Federal Centre of Hygiene, Moscow Region, Russian Federation; 3Aurisina (Trieste), Italy

Due to uncontrolled use for several decades, dichlorodiphenyltrichloroethane (DDT), probably the best known and most useful insecticide in the world, has damaged wildlife and might have

negative effects on human health. This review gives a brief history of the use of DDT in various countries and presents the results of epidemiologic and experimental studies of carcinogenesis. Even though its use has been prohibited in most countries for ecologic considerations, mainly because of its negative impact on wildlife, it is still used in some developing countries for essential

public health purposes, and it is still produced for export in at least three countries. Due to its sta-

bility and its capacity to accumulate in adipose tissue, it is found in human tissues, and there is now not a single living organism on the planet that does not contain DDT. The possible contribution of DDT to increasing the risks for cancers at various sites and its possible role as an endocrine disruptor deserve further investigation. Although there is convincing experimental evidence for the carcinogenicity of DDT and of its main metabolites DDE and DDD, epidemiologic studies have provided contrasting or inconclusive, although prevailingly negative, results. The

presence and persistence of DDT and its metabolites worldwide are still problems of great relevance to public health. Efficient pesticides that do not have the negative properties of DDT,

together with the development of alternative methods to fight malaria, should be sought with the

goal of completely banning DDT. Key words: carcinogenesis, DDT, estrogenic effects, wildlife. Environ Health Perspect 110:125-128 (2002). [Online 10 January 2002] httpl:/ehpnetl. niehs. nih.gov/docs/2002/1 10p125-128turusov/abstract. html

DDT is given credit for having helped 1 bil- lion people live free from malaria, thus sav- ing millions of lives. In 1973, after 30 years of worldwide use of DDT, a World Health Organization (WHO) report concluded that the benefits derived from use of this pesticide were far greater than its possible risks (1). After 25 additional years, the benefits of DDT can be confirmed, but its stability, ubiquitous presence, and persistence in the environment, its accumulation in adipose tissues, and its estrogenic properties raise concern about its possible long-term adverse effects. In addition to a possible carcinogenic effect, DDT has been reported to affect neu- robehavioral functions and to be associated with premature births (2,3). No living organism may be considered DDT-free. DDT is stored in all tissues, but the highest concentration occurs in fat. It has been cal- culated that it would take between 10 and 20 years for DDT to disappear from an indi- vidual if exposure would totally cease, but that DDE would possibly persist throughout the life span (4). The half-life of plasma DDE has been estimated to be approxi- mately 10 years (5).

We give here a brief history of the use of DDT, examples of its persistence in the environment, its effects on wildlife, the results of epidemiologic studies, its estrogenic effects, and the results of studies that demonstrate its ability to induce tumors in

laboratory rodents. Our emphasis is on the

possible carcinogenicity of DDT in humans.

Production and Use

DTT was first synthesized in 1874, but its insecticidal properties were not discovered until 1939 (4), and large-scale industrial production started in 1943. The low price of DDT, which fell from $1 U.S. per pound in 1945 to about $0.25 per pound in the mid-1950s (6), contributed to its worldwide use. It is of interest that the control of malaria and typhus during and immediately after World War II was achieved with relatively small quantities of DDT, while much more DDT was used after 1945 for the control of agricultural and forest pests. In the early 1960s, about 400,000 tons of DDT were used annually worldwide (70-80% of which was used for agriculture) (4,7).

All soils have a strong absorptive capacity for DDT that is related to their organic mat- ter content. DDT is toxic to freshwater and marine microorganisms, fishes, amphibians, and birds. On the basis of ecologic considerations, Sweden was the first country to ban the use of DDT beginning in January 1970 (8,9). In the former Union of Soviet Socialist Republics (U.S.S.R.) in 1970, DDT and DDT-based products were prohibited for use as pesticides by the U.S.S.R. Ministry of Health because of their persistence, bioaccu- mulation, and carcinogenicity (10). In the U.S.S.R. in 1981, the production and use of

DDT in agriculture were banned (11), but its use for public health purposes (destruction of insects such as mosquitoes, malarial plas- modia, fleas, lice, ticks) was still permitted. In March 1989, DDT was also banned for medical-disinfecting purposes. Its use, in limited volumes, was permitted for medical purposes after epidemiologic alerts and only with the permission of the state administration for sanitary matters.

In other countries, most uses of DDT were banned in 1972 or shortly thereafter because of its negative impact on wildlife (12), not because of the evidence for carcinogenicity in long-term tests in rodents. Epidemiologic studies that showed no significant long-term adverse effects were held to be more relevant than the experimental evidence of dose-related induction of liver tumors in rodents, although studies were carried out on a limited number of exposed people and had a relatively short follow-up (7,8,13).

After the prohibition of many of the uses of DDT as an insecticide in the United States in 1973, its production and use decreased rapidly in most industrialized countries. In 1985, however, about 300 tons of DDT were exported from the United States (8), although no data are available on current production. In 1990 DDT was produced by one com- pany each in Italy, India, and Indonesia with a total worldwide production estimated at about 30 million pounds (8,14).

Environmental Pollution Like most organochlorine insecticides, DDT is not very acutely toxic, an advantage that has favored its widespread use. It is slowly biodegraded, persists for a long time in the environment, and accumulates in the food chain and in the tissues of living organisms. DDT is stored in all tissues, with the highest accumulation in fat, where repeated exposures, even at low concentrations, result in a particularly high storage (4). Its widespread, uncontrolled, intensive use has resulted in worldwide pollution. DDT residues have been found in all birds and fishes analyzed, even in those living in desert areas or in the depths of the oceans. There was a widespread

Address correspondence to V. Turusov, Cancer Research Centre, Kashirskoye Shosse 24, 115478 Moscow, Russia. Telephone: 7 095 323-5500. Fax: 7 095 324-1205. E-mail: [email protected]

Received 23 May 2001; accepted 20 July 2001.

Environmental Health Perspectives * VOLUME 110 I NUMBER 2 I February 2002 125

Review * Turusov et al.

occurrence of DDT, mainly as its metabolite DDE, in the eggs of fish-eating birds, such as falcons, causing a considerable thinning of the eggshell. The consequent difficulties in

hatching resulted in a severe population decline. In parallel, high levels of DDT in lakes were a cause of reproduction failure in certain fishes (4,9,12). In spite of banning its use in many countries, DDT and its metabolites are still found all over the world.

In the United States, storage of total DDT in body fat increased from 5 ppm in 1950 to 15.6 ppm in 1956, and decreased thereafter to 3 ppm in 1980. In Italy the concentration of DDT in body fat was 4.5 ppm in 1965 and 16.7 ppm in 1970, and decreased to 8.9 ppm in 1984. In 1984 in Central America, the total DDT in body fat was 59.3 ppm (4). Although the concentrations of DDT in humans show a decreasing trend, those of DDE, which is ingested with food, in particular fish, remain constant or are decreasing only slightly. Although it was reported recently that DDE may be dechlo- rinated microbially to DDMU [1-chloro- 2,2-bis(4-chlorophenyl)ethane] (15), its persistence in marine sediments remains a reason for concern.

In developing countries there is still a particularly high exposure to residues of insecticides, mainly DDT and hexachlorocyclohexane, which are present in food. The current intakes of organochlorine insecticides in developing countries in Asia are up to 100 times greater than those in more developed countries, and the estimated intake of DDT by children is reported to be 100 times greater than the admissible daily intake (ADI) established by the Food and Agriculture Organization (FAO)/WHO in 1985 at 0.02 mg/kg (16,17). The body burden of several organochlorine insecticides, most notably p,p'-DDE [l,l-dichloro-2,2- bis(p-chlorophenyl)ethylene], is also particularly high among Inuits living in Greenland, who consume large quantities of fat from sea mammals (18). In this same population, pre- natal exposure to DDT and other organochlorine insecticides has been found to affect the immune status of the children and increase their susceptibility to infections (19).

In two large cities in the Ukraine, Kiev and Poltava, 100% of the pregnant women investigated who had no somatic disease nor occupational contact with organochlorine insecticide had DDT and its metabolites in their blood at concentrations of 0.28-76 ug/L (Kiev: 0.86-76 pg/L; Poltava: 0.28-4.5 ug/L) (20). The high values found in Kiev may be at least partly attributable to the presence of a factory producing DDT. Likewise, 100% of women who breast-fed their babies had organochlorine insecticides in their milk. The main milk contaminants were DDT and

its metabolites, but hexachlorocyclohexane was also found, and hexachlorobenzene was present in 45% of cases. In more than 90% of cases, the concentration of DDT and its derivatives was 5.8 jg/L. An important index of exposure is the content of lipophilic agents in breast milk fat. DDT was found at concentrations of 190-1,400 ng/g of milk fat, with p,p '-DDE representing 38-95% of the total content of DDT and its derivatives. As the daily consumption of breast milk is about 130 mL/kg of baby weight, the daily consumption of DDT (and its derivatives) from exclusive breast-feeding is 0.75-5.6 pg/kg of body weight with a maximum of 52 ug/kg of body weight. These concentrations greatly exceed the acceptable daily dose established for the U.S.S.R. (0.0025 lg/kg of body weight per day), which is still valid in the Ukraine (21). In another study, samples of breast milk from 197 women in two Ukrainian cities (Kiev and Dneprodzerzhinsk) were analyzed for organochlorine compounds. The median DDE concentration was 2,500 ng/g of milk fat, which is higher than that in most, but not all, other reports from Europe (22).

The levels of DDT in women's milk have decreased in most countries around the world in the last decades, with considerable differ- ences between rural and urban districts within the same country. They were between 5,000 and 10,000 pg/kg in milk fat in 1951, and around 1,000 pg/kg in the late 1990s (23). A survey carried out in the United States in 1986 showed that all samples of human milk analyzed contained DDE with levels as high as 25.4 ppm and median value of 2.4 ppm (24). In a small proportion of breast-fed babies in Mexico City, the daily intakes of DDT still exceeded the level recommended by the World Health Organization, and the estimated daily intakes of DDT by infants in a region of Thailand was up to 20 times higher than the recommended ADI (25,26).

Epidemiologic Evidence of Carcinogenicity Reports on the long-term adverse effects of occupational exposure to DDT raised the suspicion of possible carcinogenic effects in humans. Many epidemiologic studies were published up to 1991 in which the authors reported either positive or negative associa- tions between exposure to DDT and the development of tumors in humans. However, a working group convened by the International Agency for Research on Cancer qualified these studies as providing inade- quate evidence for carcinogenicity in humans (8). Since then, the results of new epidemiologic investigations have become available. An increased risk for pancreatic cancer after self-reported exposure to DDT (27,28) and

significant excess incidences of liver cancer and multiple myeloma were reported after occupational exposure to DDT (29,30). The association with an increased risk for pancreatic cancer was not confirmed in a subsequent study, but the conditions of exposure were not comparable (31).

Subsequent investigations on the long- term adverse effects of DDE confirmed the association between the concentrations of this metabolite in adipose tissue and an increased risk for mortality from liver cancer but did not confirm an increased mortality rate from cancer of the pancreas or multiple myeloma (32), nor from non-Hodgkin lymphomas (33).

DDT as an Endocrine Disruptor A number of reports have indicated that organochlorine insecticides, including DDT and its metabolites, may act as endocrine disruptors (13,34). There is evidence that DDE is an androgen receptor antagonist, and the hypothesis has been advanced that DDE may interact in an additive or multiplicative way with other endocrine-disruptive environmental pollutants (35-39). Indirect evidence of the hormonal activity of DDE comes from the observed association between levels of DDE in maternal fat and earlier weaning (40,41). Because a considerable proportion of all cancers in women are hormonally medi- ated, the possibility that xenoestrogenic substances, such as organochlorine insecticides, contribute to an increased cancer risk is particularly alarming (42). Early reports showed higher concentrations of DDT and DDE in fat tissue of individuals with mammary cancer (43), and an association between DDE blood levels and mammary cancer was reported in some epidemiologic studies (44-46). Subsequent studies provided con- flicting results, with most of them not con-

firming the association (34,47-59). The analysis of five large studies carried out in the United States, which had the limitation of not considering occupational exposures nor exposures in utero or during adolescence, did not provide evidence to support a role of DDE or polychlorinated biphenyls in increasing the risk for breast cancer (60). The hypothesis that minute doses of organochlorine insecticides act synergistically to activate human estrogen receptors could not be confirmed experimentally (39). However, the available data do not allow determination of whether the estrogenic effects of DDT and metabolites are dose related nor determination of the actual shape of the dose-response relationship.

A number of experimental studies indicate that DDT has estrogenic effects in rats: it facil- itated implantation and maintained pregnancy

VOLUME 110 I NUMBER 2 I February 2002 * Environmental Health Perspectives 126

Review * Persistence and risk of DDT

(61), exerted a uterotropic effect (62), inhibited the binding in vitro of [3H]-estradiol to the cytosolic estrogen receptor in utero (63), and accelerated mammary gland carcinogenesis induced by 2-acetylamidophenanthrene (64). In mice, the uterotropic effect of DDT increased the weight of the uterus and the development of pseudoestrus (65). A permanent, functional male-to-female sex reversal following a single exposure of eggs to o,p'- DDT was observed in medaka fish (66).

Experimental Evidence of Carcinogenicity The carcinogenicity of DDT and its metabolites has been studied in a number of labora- tories in animals including nonhuman primates. Lifetime treatment of mice with DDT induced liver tumors in a dose-related manner, and the tumors included overtly malignant metastasizing hepatoblastomas (67). The first liver tumor in male mice was seen at 50 weeks after exposure to 250 ppm of DDT in the diet, and at 65 weeks after exposure to 50, 10, or 2 ppm. In female mice the first liver tumors were seen at 60 weeks of age at the dose of 250 ppm of DDT in the diet, and after 100 weeks of age at the 50- ppm dose (68).

DDT also induced tumors in mice after treatment for a limited period of time. When treatment was continued for 15 or 30 weeks and mice were killed at various inter- vals, similar proportions of mice bearing liver tumors were observed 65, 95, and 130 weeks after the beginning of the experiment. More mice had large liver tumors at 95 and 120 weeks than at 65 weeks. These results indicate that although no new tumors were induced after cessation of exposure to DDT, the persistence of DDT-induced hepatomas did not depend on the continuous administration of DDT because the tumors that have already appeared continue to grow (68,69). After treatment of mice with DDT for six generations at four doses, no increase in the incidence of liver tumors was observed from generation to generation, as might have been expected in the presence of a genotoxic carcinogen (67).

DDT also increased incidences of lung tumors and lymphomas in mice, incidences of liver tumors in rats, and incidences of adrenal adenomas in hamsters (8). Long-term oral administration of DDT to nonhuman primates was reported to result in hepatic toxic- ity, and a few malignant and benign tumours at various sites were also found at an incidence that was of borderline statistical signifi- cance (70). In the absence of tumors in the controls, the few tumors observed may be considered to be biologically significant, thus confirming the carcinogenic effect observed in rodents (71).

The main metabolites of DDT, p,p '-DDE and p,p '-DDD [l,l-dichloro-2,2-bis(p,p- chlorophenylethane], are both carcinogenic. Exposure to DDE resulted in a high incidence of liver tumors in both male and female mice (about 100% of treated mice versus 1% in controls) with the first tumors seen at 50 weeks of age. Exposure to DDD moderately increased the incidence of liver tumors in males only, with the first tumors seen at 80 weeks of age, and markedly increased the incidence of lung tumors in animals of each sex. The combined exposure to DDE and DDD resulted in a marked increase and early appearance of liver tumors in both sexes with the first tumors seen at 70 weeks of age (68,72).

DDT and other organochlorine pesticides are cytochrome P450 inducers, and reactive products are formed during their metabolism including free radicals, epoxides, and acid chloride, which can bind covalently to cell macromolecules. Tests for genotoxic- ity gave controversial results. DDT did not induce DNA damage in bacteria or cultured rodent and human cells. It induced chromo- somal aberrations in mouse but not in rat bone-marrow cells in vivo. DDT, tetra- chlorodiphenylethane (p,p '-TDE) and p,p'- DDE inhibited gap-junctional intercellular communication (4,8).

By inducing cytochrome P450, DDT can detoxify some chemical agents and alter the susceptibility of the organism to their toxic effects. Thus, DDT prevented the lethal and adrenolytic effects of 7,12- dimethylbenz[a]anthracene in rats (73).

Conclusion The available epidemiologic and experimental data indicate that the presence and persistence of DDT and its metabolites worldwide are still problems of great relevance to public health. The possible contribution of DDT and its metabolites to the risks for cancers at various sites and their possible role as endocrine disruptors, by themselves and in combination with other organochlorine insecticides and xenoestrogenic substances, deserve further investigation.

It has been recently debated at the United Nations Environment Program whether DDT should have been totally banned together with 11 other persistent organic pollutants. The total ban of DDT was sharply criticized; in South Africa, a temporary total ban on the use of DDT for indoor spraying resulted in a sudden increase in malaria (74). Eleven countries in Africa, 7 in Asia, and 5 in Latin America still use DDT for vector disease control. There is a general consensus that limited and strictly controlled use of DDT should be allowed for public health purposes, in particular

where other effective, safe, and affordable alternatives are not available, and the benefits are clearly far superior to possible risks (75). The DDT question has stimulated heated debates from several scientists, with emphasis on the tragic consequences that a total ban of DDT could have in several developing countries (76). It would be unjustified to minimize the actual and potential risks for health and the environment caused by DDT or to downgrade confirmed evidence of adverse effects in humans (77), but it is clear that a total ban of DDT could only be achieved at a cost that poor countries, which still badly need this insecticide for public health purposes, cannot afford without substantial and long-term financial help from the richer countries.

In parallel, efficient pesticides that do not have the negative properties of DDT and its metabolites should be sought with the goal of replacing DDT completely.

REFERENCES AND NOTES

1. WHO. Safe Use of Pesticides. WHO Technical Report Series No. 513. Geneva:World Health Organization, 1973.

2. van Wendel de Joode B, Wesseling C, Kromhout H, Moge P, Garcia M, Mergler D. Chronic nervous-system effects of long-term occupational exposure to DDT. Lancet357:1014-1016 (2001).

3. Longnecker MP, Klebanoff MA, Zhou H, Brock JW. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-ges- tational-age babies at birth. Lancet 358:110-114 (2001).

4. Smith AG. Chlorinated hydrocarbon insecticides. In: Handbook of Pesticides Toxicology (Hayes WJ, Laws ER, eds). San Diego/New York:Academic Press Inc., 1991;731-915.

5. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, Speizer FE, Wolff MS. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337:1253-1258 (1997).

6. Dunlap TR. DDT: Scientists, Citizens, and Public Policy. Princeton, NJ:Princeton University Press, 1981.

7. IARC. Some Organochlorine Pesticides. IARC Monogr Eval Carcinog Risk Hum 5 (1974).

8. IARC. Occupational Exposures in Insecticide Application, and Some Pesticides. IARC Monogr Eval Carcinog Risk Hum 53 (1991).

9. WHO. DDT and Its Derivatives - Environmental Aspects. Environmental Health Criteria 83. Geneva:World Health Organization, 1989.

10. United Nations. Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments. New York:United Nations, 1984.

11. Kagan YS. General Toxicology of Pesticides [in Russian]. Kiev, USSR:Zdorovya, 1981.

12. Cooper K. Effects of pesticides on wildlife. In: Handbook of Pesticides Toxicology (Hayes WJ, Laws ER). San Diego/New York:Academic Press, lnc.,1991;463-496.

13. Keith EH. Environmental Endocrine Disruptors. New York:John Wiley & Sons, 1997.

14. Thomson WT. Agricultural Chemicals - Book 1: Insecticides. 14th ed. Fresco, CA:Thomson Publications, 1997.

15. Quensen IF, Mueller SA, Jin MX, Tiedje JM. Reductive dechlorination of DDE to DDMU in marine sediment microsomes. Science 280:722-724 (1998).

16. FAO/WHO. Pesticide Residues in Food - 1984: Report of the Joint Meeting on Pesticide Residues, Rome, 24 September-3 October 1984. Rome:Food and Agriculture Organization of the United Nations, 1985.

17. Kannan K, Tanabe S, Giesy JP, Tatsukava R. Organochlorine pesticides and polychlorinated biphenyls

Environmental Health Perspectives * VOLUME 110 I NUMBER 2 I February 2002 127

Articles * Turusov et al.

in food stuffs from Asian and Oceanic countries. Rev Environ Contain Toxicol 152:1-55 (1997).

18. Dewailly E, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber J-P, Hansen LC. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 107:823-828 (1999).

19. Dewailly E, Ayotte P, Bruneau S, Gingras S, Belles-Isles

M, Roy R. Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environ Health Perspect 108:205-211 (2000).

20. Demchenko VF, Zaets ER, Eampeka EG, Zhabchenko EA, Demchenko PI. The content of some important environmental pollutants in biological milieu of practically normal

pregnant women [in Ukrainian]. In: Actual Problems of

Ecohygiene and Toxicology, 1998;83-86. 21. Demchenko VF, Klisenko MA, Zaets ER, Zhabchenko IA.

New data of pilot studies on the pollution of breast milk of Ukrainian women with stable chlororganic pesticides [in Ukrainian]. In: Actual Problems of Ecohygiene and

Toxicology, 1998;86-89. 22. Gladen BC, Monaghan SC, Lukyanova EM, Hulchiy OP,

Shkyryak-Nyzhnyk ZA, Sericano JL, Little RE.

Organochlorines in breast milk from two cities in Ukraine. Environ Health Perspect 107:459-462 (1999).

23. Smith D. Worldwide trends in DDT levels in human breast milk. Int J Epidemol 28:179-188 (1999).

24. Rogan WJ, Gladen BC, Mckinney JD, Carreras N, Hardy P, Thullen J, Tingelstad DJ, Tully M. PCBs and DDE in human milk. Am J Public Health 76:172-177 (1986).

25. Torres-Arreola L, Lopez-Carrillo L, Torres-Sanchez L, Cebrian M, Rueda C, Reyes R, Lopez-Cervantes M. Levels of dichloro-dyphenyl-trichloroethane (DDT) metabolites in maternal milk and their determinant factors. Arch Environ Health 54:124-129 (1999).

26. Stuetz W, Prapamontol T, Erhardt JG, Classen HG.

Organochlorine pesticide residues in human milk of a

Hmong hill tribe living in Northern Thailand. Sci Total Environ 273:53-60 (2001).

27. Garabrant DH, Held J, Langholz B, Peters JM, Mack TM. DDT and related compounds and risk of pancreatic cancer. J Natl Cancer Inst 84:764-771 (1992).

28. Frizek JP, Garabrant DH, Harlow SD, Severson RK, Gillespie BW, Schenk M, Schottenfeld D. A case-control

study of self reported exposures to pesticides and pancreas cancer in south-eastern Michigan. Int J Cancer 72:62-67 (1997).

29. Brown EM, Burmeister EF. Everett GD, Blair A. Pesticide

exposure and multiple myeloma in Iowa men. Cancer Causes Control 4:153-156 (1993).

30. Cocco P, Blair A, Congia P, Saba G, Ecca AR, Palmas C.

Long term health effects of the occupational exposure to DDT. Ann NY Acad Sci 837:246-256 (1997).

31. Hoppin JA, Tobert PE, Holly EA, Brolk JW, Korrick SA, Althul LM, Zhang RN, Bracci PM, Burse VW, Needham LL. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomark Prev 9:199-205 (2000).

32. Cocco P, Kazerouni N, Zahm SH. Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect 108:1-4 (2000).

33. Baris D, Kwak LW, Rothman N, Wilson W, Manns A, Tarone RE, Hartge P. Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients. Cancer Epidemiol Biomark Prev 9:193-197 (2000).

34. Longnecker MP, Rogan WJ, Lucier G. The human health effect of DDT(dichlorodiphenylethane) and PCBs (polychlorinated biphenyls) and an overview of organochlorines in

public health. Annu Rev Public Health 18:211-244 (1997). 35. Keice WR, Stone CR. Laws SC, Gray LE, Kempainen IA,

Wilson EM. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 375:581-585 (1995).

36. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estro-

genic. Environ Health Perspect 103:582-587 (1995). 37. de Solla SR, Bishop CA, Van der Kraak G, Brooks RJ.

Impact of organochlorine contamination on level of sex hormones and external morphology of common snapping

turtles (Chelidra serpentina) in Ontario, Canada. Environ Health Perspect 106:253-260 (1998).

38. Podreka S, Georges A, Maher B, Limpus CJ. The environmental contaminant DDE fails to influence the outcome of sexual differentiation in the marine turtle Chelunia mydas. Environ Health Perspect 106:185-188 (1998).

39. Ramamoorthy K, Wang F, Clien IC, Safe S, Norris JD, McDonnel DP, Gaido KW, Bocchinfuso WP, Korach KS.

Potency of combined estrogenic pesticides [Letter]. Science 275:405-406 (1996).

40. Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P, Thullen J, Tingelstad J, Tully M. Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethane (DDE) in human milk: effects on growth, morbidity, and duration of lactation. Am J Public Health 77:1294-1297 (1987).

41. Gladen BC, Rogan WJ. DDE and shortened duration of lactation in a Northern Mexican town. Am J Public Health 85:504-508 (1995).

42. Wolff MS, Collman GW,Barrett JC, Huff J. Breast cancer and environmental risk factors: epidemiological and

experimental findings. Ann Rev Pharmacol Toxicol 36:573-596 (1996).

43. Wasserman M, Tomatis L, Wasserman D, Day NE, Groner

Y, Lazarivici S, Rosenfeld D. Epidemiology of organochlorine insecticides in the adipose tissue of Israelis. Pestic MonitJ 8:1-7 (1974).

44. Wolf MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).

45. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Natl Cancer Inst 86:589-599 (1994).

46. Dewailly E, Dodin S. Verreault R, Ayotte P, Sauve L, Morin J, Brisson J. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86:232-234 (1994).

47. Lopez-Carillo L, Blair A, Lopez-Cervantes M, Cebrian M, Rueda C, Reyes R, Mohar A, Bravo J. Dichloro-

diphenyltrichloroethane serum level and breast cancer risk: a case-control study from Mexico. Cancer Res 57:3728-3732 (1997).

48. van't Veer P, Lobbezoo IE, Martin-Moreno JM, Guallar E, Gomez-Aracena J, Kardinaal AF, Kohlmeier L, Martin BC, Strain JJ, Thamm M, et al. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control

study. Br Med J 315:81-85 (1997). 49. Schecter A, Toniolo P, Dai EC, Tliuy LT, Wolff MS. Blood

levels of DDT and breast cancer risk among women liv-

ing in the north of Vietnam. Arch Environ Contam Toxicol 33:453-456 (1997).

50. Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Scisterman EF, et al. Environmental

organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomark Prev 7:181-188 (1998).

51. Liljegien G, Hardell I, Lindstrom G, Dahl P, Magnuson A. Case-control study on breast cancer and adipose tissue concentration of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7:135-140 (1998).

52. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hai-

twig HB. Organoclorine exposure and risk of breast cancer. Lancet 352:1816-1820 (1998).

53. Zheng T, Holford TR, Mayne ST, Ward B, Carter D, Owens

PH, Dubrow R, Zahm SH, Boyle P, Archibeque S, et al. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 150:453-458 (1999).

54. Helzlsouer K, Alberg Al, Huang H, Hoffinian SC, Strickland

PT, Brock EW, Burse VW, Needham EE, Bell DA, Lavigne JA, et al. Serum concentrations of organochlorine com-

pounds and the subsequent development of breast cancer. Cancer Epidemiol Biomark Prev 8:525-532 (1999).

55. Millikan R, De Voto E, Duell EJ, Tse CK, Savitz DA, Beach

J, Edmiston S, Jackson S, Newman B. Dichloro-

diphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomark Prev 9:1233-1240 (2000).

56. Stellman SD, Djordevic MV, Britton JA, Nuscart JE, Citron ML, Kemeny M, Busch E, Lin G. Breast cancer in relation to adipose concentration of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomark Prev 9:1241-1249 (2000).

57. Ward EW, Schulte P, Grajewski B, Andersen A, Patterson DG Jr, Turner W, Jellum E, Deddens JA, Friedland L, Roeleveld N, et al. Serum organochloric levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomark Prev 9:1357-1367 (2000).

58. Demers A, Ayotte P, Briusson J, Dodin S, Robert J, Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomark Prev 9:161-166 (2000).

59. Wolff MS, Zeeleniuch-Jacquotte A, Dubin N, Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomark Prev 9:241-277 (2000).

60. Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz

GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, et al. 1,1-Dichloro-2,2 bis(p- chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 93:768-775 (2001).

61. Johnson DC, Sen M, Dey SK. Differential effects of

dichlorodiphenyltrichloroethane analogs, chlordecone, 2,3,7,8-tetrachlorodibenzo-p-dioxin on establishment of

pregnancy in the hypophysectomized rat. Proc Soc Exp Biol Med 199:42-48 (1992).

62. Welch RM, Levin W, Conney AH. Estrogenic action of DDT and its analogues. Toxicol Appl Pharmacol 14:358-367

(1969). 63. Nelson JA. Effects of dichlorodiphenyltrichloroethane

(DDT) analogs and polychlorinated biphenyl (PCB) mix- tures on 173-[3H]estradiol binding to rat uterine receptor. Biochem Pharmacol 23:447-451 (1974).

64. Scribner ID, Mottet NK. DDT acceleration of mammary gland tumors in the male Sprague-Dawley rat by 2-acety- lamidophenantrene. Carcinogenesis 2:1235-1239 (1981).

65. Morozova OV, Riboli E, Turusov VS. Estrogenic effect of DDT in CBA female mice. Exp Toxicol Pathol 49:483-485 (1997).

66. Edmunds JSG, McCarthy RA, Ramsdell JS. Permanent and functional male-to-female sex reversal in d-rR strain Medaka (Oryzias latipes) following egg microinjection of

o.p'-DDT. Environ Health Perspect 108:219-224 (2000). 67. Turusov VS, Day NE, Tomatis L, Gati E, Charles RT.

Tumors in CF-1 mice exposed for six consecutive generations to DDT. J Natl Cancer Inst 51:983-997 (1973).

68. Tomatis L, Turusov V. Studies on the carcinogenicity of DDT. Gann Monogr 17:219-241 (1975).

69. Tomatis L, Turusov V, Charles RT, Boiocchi M, Gati E. Liver tumours in CF-1 mice exposed for limited periods to technical DDT. Z Krebsforsch 82:25-35 (1974).

70. Takayama S, Sieber SM, Dalgard DW, Thorgeirson UP, Adamson RH. Effects of long-term oral administration of DDT on nonhuman primates. J Cancer Res Clin Oncol 125:219-225 (1999).

71. Tomatis E, Huff J. Evidence of carcinogenicity of DDT in nonhuman primates [Letter]. J Cancer Res Clin Oncol 126:246 (2000).

72. Tomatis L, Turusov V, Charles RT, Boicchi M. Effect of long- term exposure to 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene, to 1,1-dichloro-2,2-bis(p-chlorophenyl) ethane, and to the two chemicals combined on CF-1 mice. J Natl Cancer Inst 52:883-891 (1974).

73. Turusov VS, Chemeris GY. Modification of toxic effects of DMBA by DDT and DDE. Chem Biol Interact 15:295-298

(1976). 74. Attaran A, Maharaj R. DDT for malaria control should not

be banned. Br Med J 321:1403-1404 (2000). 75. Liroff R. Commentary: reduction and elimination of DDT

should proceed slowly. Br Med J 321:1404-1405 (2000). 76. Ferriman A. Attempts to ban DDT have had tragic conse-

quences. Br Med J 322:1270 (2001). 77. Ross GL, Rogan WJ, Schletter T, Raffensperger C,

McCally M, Orris P, Tickner J, Liroff RA, Cormican M, Collignon P, et al. The DDT question. Lancet 356:1189-1191

(2000).

VOLUME 1101 NUMBER 2 1 February 2002 * Environmental Health Perspectives 128

Documents

Brogan & Partners - Sites@Duke | sites.duke.edusites.duke.edu/malaria/files/2012/07/Turusov-et-al_2002.pdf · 2012. 9. 24. · Moscow, Russia. Telephone: 7 095 323-5500. Fax: 7 095